Your browser is no longer supported. Please, upgrade your browser.
Settings
BIOC Biocept, Inc. daily Stock Chart
BIOC [NASD]
Biocept, Inc.
Index- P/E- EPS (ttm)-10.69 Insider Own5.72% Shs Outstand4.37M Perf Week-10.38%
Market Cap4.15M Forward P/E- EPS next Y-5.58 Insider Trans0.00% Shs Float3.83M Perf Month-52.74%
Income-21.60M PEG- EPS next Q-1.60 Inst Own17.10% Short Float6.95% Perf Quarter-71.21%
Sales3.40M P/S1.22 EPS this Y63.70% Inst Trans117.69% Short Ratio1.35 Perf Half Y-85.93%
Book/sh3.23 P/B0.29 EPS next Y- ROA-215.50% Target Price5.13 Perf Year-95.76%
Cash/sh2.06 P/C0.46 EPS next 5Y40.00% ROE-455.60% 52W Range1.00 - 24.60 Perf YTD-95.44%
Dividend- P/FCF- EPS past 5Y45.80% ROI-452.70% 52W High-96.14% Beta1.59
Dividend %- Quick Ratio2.50 Sales past 5Y115.40% Gross Margin- 52W Low-5.00% ATR0.17
Employees42 Current Ratio2.60 Sales Q/Q-27.30% Oper. Margin- RSI (14)21.97 Volatility12.52% 12.41%
OptionableYes Debt/Eq0.19 EPS Q/Q63.00% Profit Margin- Rel Volume1.26 Prev Close1.03
ShortableYes LT Debt/Eq0.11 EarningsNov 13 AMC Payout- Avg Volume197.14K Price0.95
Recom2.30 SMA20-34.62% SMA50-51.71% SMA200-81.58% Volume249,323 Change-7.77%
Nov-14-17Reiterated Chardan Capital Markets Buy $2.50 → $1.50
Jun-02-17Initiated Chardan Capital Markets Buy $2.50
Jun-06-16Initiated ROTH Capital Buy $1.20
Aug-19-15Initiated H.C. Wainwright Buy $4
Jun-03-14Initiated Aegis Capital Buy $16
Nov-29-18 08:09AM  The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved Benzinga
Nov-20-18 01:19PM  What Kind Of Shareholder Appears On The Biocept Incs (NASDAQ:BIOC) Shareholder Register? Simply Wall St.
Nov-13-18 04:05PM  Biocept Reports Third Quarter 2018 Financial Results PR Newswire
Nov-06-18 08:05AM  Biocept to Release Third Quarter 2018 Financial Results and Host Investor Conference Call on November 13, 2018 PR Newswire -6.73%
Nov-05-18 08:05AM  Biocept Announces New Executive Hires to its Sales and Marketing Organization PR Newswire +5.05%
Nov-01-18 11:28AM  Biocept (BIOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks +5.79%
Oct-23-18 08:05AM  Biocept to Present at the Dawson James Securities Small Cap Growth Conference on October 30 PR Newswire
Oct-18-18 08:05AM  Biocept Obtains Japanese Patent for its Target Selector Oncogene Mutation Enrichment and Detection Platform PR Newswire
Sep-25-18 08:05AM  Biocept to Present at The MicroCap Conference in New York on October 2 PR Newswire
Sep-24-18 08:05AM  Biocept Awarded Patent in Hong Kong for its Target Selector Platform Using Antibodies and a Microchannel to Perform Liquid Biopsy PR Newswire
Sep-21-18 07:00AM  Biocept Announces Pricing of $2.5 Million Registered Direct Offering Priced at Market PR Newswire -11.98%
Sep-10-18 08:05AM  Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer PR Newswire
Sep-06-18 08:05AM  Biocept's Target Selector Platform Featured in Two Poster Presentations at the IASLC 19th World Conference on Lung Cancer PR Newswire
Aug-23-18 10:30AM  Highmark Health's VITAL Innovation Program testing benefits of Biocept's liquid biopsy platform for improving outcomes and lowering costs of treatment for patients with non-small cell lung cancer PR Newswire +18.33%
Aug-15-18 08:48AM  The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue Benzinga -12.88%
Aug-14-18 04:05PM  Biocept Reports Second Quarter 2018 Financial Results PR Newswire -6.17%
Aug-09-18 04:05PM  Biocept to Release Second Quarter 2018 Financial Results and Host Investor Conference Call on August 14, 2018 PR Newswire
08:05AM  Biocept Announces $11.6 Million in Expected Gross Proceeds from Recently Expired Rights Offering PR Newswire
Aug-06-18 08:05AM  Biocept Announces Agreement with Managed Care Plan to Study the Benefits of Implementing Liquid Biopsy to Improve Patient Outcomes and Lower Healthcare Costs PR Newswire
Aug-02-18 08:05AM  Biocept Awarded Patent in Canada for its Target Selector CTC Platform PR Newswire
Jul-31-18 08:05AM  European Patent Granted for Biocept's Target Selector Oncogene Mutation Enrichment and Detection Platform PR Newswire
Jul-23-18 08:05AM  Biocept and UC San Diego Moores Cancer Center Announce Collaboration to Study Feasibility of Liquid Biopsy to Predict Disease Recurrence in Solid Tumors and Response to Therapy PR Newswire
Jul-19-18 09:00AM  Biocept Reminds Investors of Today's Deadline to be a Shareholder of Record PR Newswire
Jul-16-18 08:39AM  Biocept, Inc. (BIOC) Soars: Stock Adds 9.8% in Session Zacks
08:10AM  Today's Research Reports on Stocks to Watch: Biocept and Johnson and Johnson ACCESSWIRE
Jul-13-18 04:49PM  Why RH, Biocept, and Lowe's Jumped Today Motley Fool +9.77%
03:46PM  BIOC: Whats Going on With Biocept Stock? InvestorPlace
01:02PM  Why Biocept, Inc. Is Rebounding Big-Time Today Motley Fool
11:00AM  Biocept Rallies On Marketing Agreement For Proprietary Liquid Biopsy Tests Benzinga
08:05AM  Biocept Enters into Agreement with Alliance Global FZ to Market and Distribute Liquid Biopsy Testing in the Middle East, Southeast Asia, and Africa Region PR Newswire
Jul-12-18 12:26PM  Why Biocept, Inc. Stock Is Plunging Today Motley Fool -17.30%
08:00AM  Today's Research Reports on Trending Tickers: Biocept and Myriad Genetics ACCESSWIRE
Jul-11-18 09:00AM  Biocept Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering PR Newswire +115.22%
Jun-25-18 08:05AM  Biocept Highlights Recent Progress and Outlines Near-Term Strategic Priorities in CEO Letter to Stockholders PR Newswire
Jun-20-18 07:15AM  Free Stock Performance Review on Agilent Technologies and Three Additional Medical Research Stocks ACCESSWIRE
Jun-18-18 08:05AM  Published Case Report Demonstrates the Clinical Utility of Biocept's CTC Platform in the Management of Patients with Metastatic Breast Cancer PR Newswire
Jun-11-18 08:05AM  VWR, Part of Avantor, and Biocept Announce the Launch of CEE-Sure Blood Collection Tubes for cfDNA and CTCs PR Newswire
May-29-18 08:05AM  Biocept to Present at the 8th Annual LD Micro Invitational Conference on June 5 PR Newswire
May-17-18 08:30AM  Agilent Technologies and Three More Healthcare Stocks Under Our Scanner ACCESSWIRE +5.21%
May-15-18 04:05PM  Biocept Reports First Quarter 2018 Financial Results PR Newswire
May-08-18 08:05AM  Biocept to Release First Quarter 2018 Financial Results and Host Investor Conference Call on May 15, 2018 PR Newswire
May-01-18 08:05AM  Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung Cancer PR Newswire +6.83%
Apr-27-18 08:05AM  Published Case Study Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for ALK Rearrangements PR Newswire
Apr-06-18 08:05AM  Biocept to Webcast Presentation at the 7th Annual MicroCap Conference PR Newswire
07:40AM  Free Post Earnings Research Report: Exact Sciences Quarterly Revenues Jumped 148.02% ACCESSWIRE
Apr-03-18 08:05AM  Biocept to Present at the 7th Annual MicroCap Conference PR Newswire -13.35%
Mar-29-18 08:05AM  Biocept Obtains Patent for its Target Selector Molecular Biomarker Technology in China PR Newswire -7.81%
Mar-28-18 04:05PM  Biocept Reports 2017 Fourth Quarter and Full Year Financial Results PR Newswire
12:00PM  Biocept, Inc. to Host Earnings Call ACCESSWIRE
08:10AM  Biocept Inc, Liquid Biopsy is Coming, Analysts Review, Biopsy Market and Upcoming Milestones ACCESSWIRE
08:05AM  Biocept and Thermo Fisher Scientific Enter into Technology and Commercial Collaboration PR Newswire
Mar-20-18 08:05AM  Biocept to Present Recent Advances in Biomarker Identification from Liquid Biopsies at GTCbio's 11th Biomarker Summit PR Newswire
Mar-15-18 08:05AM  Biocept's Target Selector Platform Featured in Two Poster Presentations at the 2018 American Association for Cancer Research Annual Meeting PR Newswire
Mar-12-18 08:05AM  Biocept to Release 2017 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 28, 2018 PR Newswire
Mar-06-18 08:05AM  Biocept to Present at the 30th Annual ROTH Conference PR Newswire
Feb-05-18 08:05AM  Biocept Receives Additional Patent Issuances in Three Major International Territories for its Target Selector Platform PR Newswire -6.72%
Jan-31-18 05:16PM  Dawson James Securities Announces Closing of Approximately $14.78M Public Offering for Biocept, Inc. ACCESSWIRE
Jan-30-18 04:05PM  Biocept Announces Closing of $14.8 Million Public Offering of 32,854,606 Shares of Common Stock and Warrants to Purchase 32,854,606 Shares of Common Stock PR Newswire
08:05AM  Biocept Comments on Updated Consensus Medical Guidelines Recommending Liquid Biopsy for Profiling of Tumor Biomarkers to Assist with the Treatment of Patients with Lung Cancer PR Newswire
Jan-26-18 01:15PM  Biocept Inc (BIOC) Dilutes Shareholders a Second Time in Two Months SmarterAnalyst -26.76%
06:31AM  Biocept Announces Pricing of $15.0 Million Public Offering of 33,333,333 Shares of Common Stock and Warrants to Purchase 33,333,333 Shares of Common Stock PR Newswire
Jan-24-18 04:04PM  Colony NorthStar, Kimco Realty Slide into Wednesdays 52-Week Low Club 24/7 Wall St. -8.65%
Jan-17-18 01:45PM  Scientists seek super-shot for flu 100 years after pandemic Associated Press
08:59AM  Century after pandemic, science takes its best shot at flu Associated Press
Jan-09-18 08:05AM  Biocept Study Shows Incorporation of Thermo Fisher QuantStudio 5 PCR Instrument into Target Selector Platform Improves Sensitivity and Specificity in Detection of Lung Cancer Biomarkers PR Newswire
Jan-04-18 08:05AM  Biocept Obtains Patent in Australia for its Molecular Biomarker Technology For the Detection of Cancer-Associated Mutations in Blood, Tissue, and Other Biological Sources PR Newswire
Dec-28-17 11:52AM  ETFs with exposure to Biocept, Inc. : December 28, 2017 Capital Cube
Dec-19-17 11:47AM  GlaxoSmithKline (Egypt): Strong price momentum but will it sustain? Capital Cube
Dec-18-17 08:05AM  Biocept Signs In-Network Provider Agreement with Wellmark Blue Cross Blue Shield Expanding Coverage for its Target Selector Platform in Iowa and South Dakota PR Newswire
Dec-11-17 01:34PM  ETFs with exposure to Biocept, Inc. : December 11, 2017 Capital Cube -5.39%
Dec-06-17 12:53PM  What Spooked Biocept Inc (BIOC) Investors Today SmarterAnalyst -33.04%
08:05AM  Biocept Announces Pricing of Public Offering of up to 4,925,936 Shares of Common Stock PR Newswire
08:00AM  Todays Research Reports on Stocks to Watch: Neuralstem, Inc. and Biocept Inc. ACCESSWIRE
Dec-05-17 01:57PM  Biocept Inc Shares Skyrocket on Surprise Patent Victory SmarterAnalyst +69.12%
08:05AM  First U.S. Patent Issued for Biocept's Target Selector Oncogene Mutation Enrichment and Detection Liquid Biopsy ctDNA Platform PR Newswire
Nov-29-17 11:12AM  ETFs with exposure to Biocept, Inc. : November 29, 2017 Capital Cube -9.69%
08:20AM  Biocept, Inc. :BIOC-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 Capital Cube
Nov-28-17 08:05AM  Biocept and UC San Diego Medical Center Announce Clinical Study Collaboration to Demonstrate Utility of Biocept's Liquid Biopsy Test in Immunotherapy PR Newswire +24.98%
Nov-13-17 11:51AM  ETFs with exposure to Biocept, Inc. : November 13, 2017 Capital Cube -15.81%
Nov-09-17 04:05PM  Biocept Reports Third Quarter 2017 Financial Results PR Newswire +8.77%
10:10AM  Biocept, Inc. to Host Earnings Call ACCESSWIRE
Nov-02-17 11:53AM  ETFs with exposure to Biocept, Inc. : November 2, 2017 Capital Cube
08:05AM  Biocept to Release Third Quarter Financial Results and Host Investor Conference Call on November 9, 2017 PR Newswire
Oct-23-17 10:23AM  ETFs with exposure to Biocept, Inc. : October 23, 2017 Capital Cube -5.61%
Oct-18-17 08:05AM  Biocept Launches Pathology Partnership Initiative Expanding Access of Proprietary Liquid Biopsy Testing to Community Pathologists and Hospitals PR Newswire
Oct-11-17 08:05AM  Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept's Clinical Advisory Board PR Newswire
Oct-10-17 11:03AM  ETFs with exposure to Biocept, Inc. : October 10, 2017 Capital Cube
Oct-04-17 06:46PM  What You Must Know About Biocept Incs (BIOC) Risks Simply Wall St.
09:20AM  Biocept, Inc. :BIOC-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017 Capital Cube
Oct-03-17 08:05AM  Biocept and Miraca Life Sciences Enter Into Marketing Agreement to Expand Target Selector Testing in the United States PR Newswire
Sep-19-17 09:35AM  5 Medtech Stocks to Steer Clear of Amid Political Chaos Zacks
Sep-05-17 08:05AM  Biocept Launches Liquid Biopsy Test for NRAS Mutations PR Newswire
Aug-28-17 08:05AM  Biocept to Present at the 6th Annual Gateway Conference on September 6, 2017 in San Francisco PR Newswire
Aug-17-17 08:05AM  Biocept and UT Southwestern Medical Center Announce Clinical Study to Profile and Monitor Non-Small Cell Lung Cancer Patients with ALK Rearrangements PR Newswire
Aug-14-17 08:05AM  Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR PR Newswire
Aug-10-17 04:05PM  Biocept Reports Second Quarter 2017 Financial Results PR Newswire
12:30PM  Investor Network: Biocept, Inc. to Host Earnings Call ACCESSWIRE
08:05AM  Biocept Announces Private Placement of $2.2 Million of Common Stock with Ally Bridge LB Healthcare Master Fund PR Newswire
Aug-07-17 08:05AM  Biocept Executes Preferred Provider Agreement with Scripps Health Plan Expanding Patient Coverage for its Liquid Biopsy Platform PR Newswire +7.69%
Aug-03-17 07:47PM  ETFs with exposure to Biocept, Inc. : August 3, 2017 Capital Cube
Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company's cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring in order to identify resistance mechanisms. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer, and ovarian cancer. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.